In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
|Original language||English (US)|
|Journal||Journal of Pediatrics|
|State||Published - Apr 2022|
All Science Journal Classification (ASJC) codes
- Pediatrics, Perinatology, and Child Health